New Research Studies Future Treatments on Marburg Virus

Abstract

Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe, often fatal illness in humans. The virus causes severe viral haemorrhagic fever in humans. The identification of the natural reservoir of this virus should also foster the development health measures and prevention campaigns to the population to reduce the apparition and emergence of potential outbreaks of hemorrhagic fever. The emergence of Marburg virus (MARV) in Guinea and Ghana triggered the assembly of the MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine research and development aiming to facilitate a rapid response to this infectious disease threat. While much is being investigated to devise a vaccine, it is important to educate Health Care Workers (HCWs) and close contacts facing the illness